Corcept Therapeutics | CORT - Capitale Ordinario

Prezzo Delle Azioni
49.73
Cambio Giornaliero
3.21 6.89%
Mensile
17.03%
Annuale
-31.67%
Q2 Previsione
45.07




Capitale Ordinario Cambiamento Data
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Ardelyx USD 244.35M 1.38M 2025-12
Assertio Holdings USD 9K 0 2023-12
Aurora Cannabis CAD 56.71M 134.13K 2025-12
BioMarin Pharmaceutical USD 192.3M 201K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 368.28M 35.9M 2025-12
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Esperion Therapeutics USD 245.22M 39.79M 2025-12
J&J USD 2.41B 1.74M 2025-12
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
Merck USD 2.47B 12.72M 2025-12
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Novartis USD 1.91B 10.64M 2025-12
Novartis USD 1.91B 10.64M 2025-12
Omeros USD 611K 17K 2023-12
Pacira USD 39.31M 1.81M 2026-03
Pfizer USD 5.69B 1000K 2025-09
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
TG Therapeutics USD 155.21M 2.81M 2025-09